ABSORPTION
OF
INORGANIC
IRON
59FE2
IN
RELATION
TO
IRON
STORES
IN
PANCREATIC
EXOCRINE
INSUFFICIENCY
DUE
TO
CYSTIC
FIBROSIS
THE
ABSORPTION
OF
59FE
FROM
A
DIAGNOSTIC
056
MG
59FE2
DOSE
WAS
MEASURED
BY
4PIGEOMETRY
WHOLE
BODY
COUNTING
AND
RELATED
TO
THE
AMOUNT
OF
STAINABLE
DIFFUSE
CYTOPLASMATIC
NON
HEME
STORAGE
IRON
IN
THE
BONE
MARROW
MACROPHAGES
OF
CHILDREN
WITH
CYSTIC
FIBROSIS
WHEN
THE
STORAGE
IRON
WAS
WITHIN
THE
NORMAL
RANGE
2
CHILDREN
WITH
CYSTIC
FIBROSIS
ABSORBED
1038
XASD2193
OF
THE
ORAL
59FE2
DOSE
WHICH
IS
IDENTICAL
WITH
THE
59FEABSORPTION
IN
NORMAL
CHILDREN
WITH
NORMAL
IRON
STORES
9452387
DEPLETED
IRON
STORES
CAUSED
AN
INCREASE
OF
59FEABSORPTION
TO
4395
XA
SD6219
IN
CHILDREN
WITH
CYSTIC
FIBROSIS
AND
TO
45100
XA
SD7318
IN
CONTROL
CHILDREN
THE
INTERRUPTION
OR
CONTINUATION
OF
PANCREATIN
MAINTENANCE
THERAPY
AND
THE
SIMULTANEOUS
ADMINISTRATION
OF
115
G
PANCREATIN
DID
NOT
INFLUENCE
59FE2
ABSORPTION
IN
CYSTIC
FIBROSIS
THERE
IS
NO
EVIDENCE
FOR
A
PANCREATIC
FACTOR
REQUIRED
FOR
OR
INHIBITING
INORGANIC
AND
FOOD
IRON
ABSORPTION
IN
HUMAN
BEINGS
IRON
ABSORPTION
IS
CONTROLLED
ALSO
IN
CYSTIC
FIBROSIS
CHIEFLY
BY
THE
AMOUNTS
OF
AVAILABLE
STORAGE
IRON
IT
IS
THEREFORE
NOT
JUSTIFIED
TO
APPREHEND
THE
DEVELOPMENT
OF
HEMOSIDEROSIS
IN
CHILDREN
WITH
CYSTIC
FIBROSIS
WHO
ARE
NOT
OR
NOT
SUFFICIENTLY
TREATED
WITH
PANCREATIN
